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MembranesThe endoplasmic reticulum (ER) is an interconnected network of tubular and planar membranes that sup-
ports the synthesis and export of proteins, carbohydrates and lipids. Phospholipids, in particular phosphati-
dylcholine (PC), are synthesized in the ER where they have essential functions including provision of
membranes required for protein synthesis and export, cholesterol homeostasis, and triacylglycerol storage
and secretion. Coordination of these biological processes is essential, as highlighted by ﬁndings that link
phospholipid metabolism in the ER with perturbations in lipid storage/secretion and stress responses, ulti-
mately contributing to obesity/diabetes, atherosclerosis and neurological disorders. Phospholipid synthesis
is not uniformly distributed in the ER but is localized at membrane interfaces or contact zones with other or-
ganelles, and in dynamic, proliferating ER membranes. The topology of phospholipid synthesis is an impor-
tant consideration when establishing the etiology of diseases that arise from ER dysfunction. This review
will highlight our current understanding of the contribution of phospholipid synthesis to proper ER function,
and how alterations contribute to aberrant stress responses and disease. This article is part of a Special Issue
entitled: Functional and structural diversity of endoplasmic reticulum.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The endoplasmic reticulum (ER) is the primary site for phospholipid
synthesis and also accounts for >60% of phospholipid mass in a variety
of cell types. At the same time, the phospholipid content and composi-
tion of the ER are in constant ﬂux owing to constitutive and regulated; AGPAT, acylglycerolphosphate
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rights reserved.export to other organelles, and secretion of lipids to the extracellular
environment by specialized cells such as hepatocytes, intestinal epithe-
lial cells and macrophages. Lipid biosynthetic capacity must match
these export demands in order to maintain ER integrity and the mem-
brane requirements of distal organelles. The extended tubular and pla-
nar ER network extends to all regions of the cell where it interfaces at
membrane contact siteswith the PM,mitochondria andGolgi apparatus
for the purpose of lipid transfer, integration of metabolic pathways and
calcium homeostasis. In this context, it is increasingly apparent that
phospholipid synthesis in the ER is spatially integrated with the struc-
ture and function of other organelles, which in turn can be negatively
impacted by disturbances in ER function. The enzymology and regula-
tion of ER-associated phospholipid biosynthetic pathways have been
reviewed in detail [1–3]. Thus we will focus on the impact of phospho-
lipid biosynthesis on ER membrane organization and expansion, sterol
and triacylglycerol (TAG) synthesis and deposition, and organelle inter-
actions. This reviewwill emphasize the importance of phosphatidylcho-
line (PC) owing to the preponderance of information on its role in ER
structure, function and pathologies.
2. PC synthesis and ER function
2.1. PC biosynthesis and regulation
Phosphatidylcholine (PC) is the most abundant phospholipid in
eukaryotic cell membranes, and its biosynthesis is essential for ER
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sponse (UPR). In mammalian cells, two de novo biosynthetic path-
ways for PC are localized to the ER. The CDP-choline pathway, ﬁrst
described by Eugene Kennedy and co-workers in the 1950s following
their seminal discovery of the use of cytosine nucleotides in phos-
pholipid synthesis [4,5], is responsible for the majority of de novo PC
production in tissues. In contrast, phosphatidylethanolamine (PE)
N-methyltransferase (PEMT) catalyzes the synthesis of PC by succes-
sive methylation of the amino headgroup of PE, a reaction that is only
quantitatively important in hepatocytes [6,7] and differentiated adi-
pocytes [8,9]. PC produced by these pathways is further modiﬁed
through the Lands cycle by replacement of fatty acids at the sn-2 po-
sition by the combined action of the calcium-independent Group VIA
phospholipase A2 (iPLA2) and reacylation by lyso-PC acyltransferase
[10,11].
The CDP-choline pathway consists of three enzyme reactions that
convert choline to PC: i) phosphorylation of choline, catalyzed by cho-
line kinase; ii) transfer of CMP from CTP to phosphocholine forming
CDP-choline, catalyzed by CTP:phosphocholine cytidylyltransferase
(CCT); and iii) transfer of phosphocholine from CDP-choline to diac-
ylglycerol (DAG), catalyzed by CDP-choline (ethanolamine): diac-
ylglycerol choline (choline/ethanolamine) phosphotransferases (CPT
and CEPT) [12,13] (Fig. 1). Both choline kinase and CCT are soluble en-
zymes but the terminal step in the pathway catalyzed by CEPT and
CPT occurs in the ER and Golgi apparatus, respectively [14–16]. CCT
is generally considered the rate-limiting and regulated enzyme in
the CDP-choline pathway, although evidence of mitogen stimulationMT
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ulatory role for choline kinase during cell proliferation. Themammalian
PCYT1a and PCYT1b genes encode the CCTα and CCTβ enzymes, respec-
tively. CCTα is ubiquitously expressed, whereas CCTβ1, β2 and β3 splice
variants display restricted tissue distribution [22–24]. Speciﬁc domains
in CCTα regulate cell localization and activity: i) a cluster of N-terminal
positively charged amino acids followed by an acidic tract constitute a
nuclear localization signal [25]; ii) a catalytic core that is highly con-
served among nucleotidyltransferases [26], iii) a membrane-binding
(M) domain that regulates CCTα activity through reversible membrane
association [27,28]; and iv) a C-terminal phosphorylation (P) domain
containing 16 serine phosphorylation sites that modulates enzyme ac-
tivity by partially interfering with membrane binding [29,30].
An important regulatory feature governing PC synthesis is the re-
versible association of CCTα with membranes in response to lipid ac-
tivators and/or membrane structure. In the presence of membranes
enriched in lipid activators, domain M undergoes a conformational
switch from a structure dominated by random coil conformations to
an ordered amphipathic α-helix, creating a hydrophobic face for in-
sertion into membranes [31]. Electrostatic interactions at the bound-
aries of the hydrophobic face also promote membrane binding of
CCTα [32]. The inhibition and activating functions of domain M are
localized to a conserved 22-amino acid segment that interacts with
the catalytic domain and membranes [33]. In the absence of mem-
branes, this segment of the amphipathic helix silences catalytic activ-
ity by association with the active site helix αE; association with
membranes relieves inhibition, resulting in a ~100-fold elevation inPS
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vivo studies have identiﬁed two distinct classes of membrane lipid ac-
tivators of CCT. Class I activators include anionic lipids and fatty acids
that interact with positively charged lysine residues near the interfa-
cial region in domain M [27,36]. In cultured cells, endogenous or
exogenous sources of fatty acids promote membrane translocation
and activation of CCTα activity [37–39]. Class II activators, including
DAG and unsaturated PE, promote curvature elastic stress in mem-
branes and introduce gaps in the packing of polar head groups within
planar bilayers, favoring insertion of the hydrophobic face of the do-
main M amphipathic helix [40,41]. Lipids that negatively regulate
CCTα membrane binding include lyso-PC [42], sphingosine [43] and
ceramide [44]. Since PC is zwitterionic and forms planar bilayers, its
relative abundance reduces lateral packing stress and negative charge
leading to reduced membrane association and activity of CCTα. Thus
domain M ‘senses’ the relative membrane abundance of the precur-
sors and product of the CDP-choline pathway, resulting in appropri-
ate changes to CCTα activity and PC homeostasis.
CCTα is nuclear-localized in many cells and tissues [45], and trans-
locates to the inner nuclear envelope when activated [46]. Nuclear
CCTα may serve to coordinate PC synthesis with membrane expan-
sion during the cell cycle [47] or support the synthesis of an
endonuclear pool of PC [48] (Fig. 1). It has been postulated that
CCTα shuttles between the nucleus and cytoplasm in response to
stimulatory signals, and that CDP-choline for bulk PC synthesis is
formed primarily by extranuclear CCTα following its translocation
to the ER [49]. In support of this theory, CCTα is cytoplasmic in type
II alveolar cells [50] and nuclear/cytoplasmic in hepatocytes [51],
both of which require increased PC biosynthetic capacity for secretion
of surfactant and lipoproteins, respectively. On the other hand, the
exclusive nuclear localization GFP-tagged CCTα in synchronized
cells is independent of cell cycle mediated ﬂuctuations in PC biosyn-
thesis [52]. This suggests that the CDP-choline produced by nuclear
CCTα is available to CEPT in the ER for conversion to PC or the steady-
state nuclear distribution of CCTα reﬂects a rapid export/import cycle
that facilitates the synthesis of CDP-choline at the ER.2.2. Intersection of phospholipid and TAG biosynthesis
The synthesis of PC and TAG, required for the assembly of cellular
lipid storage droplets and lipoproteins, utilizes DAG that is made de
novo from phosphatidic acid (PA) synthesized by a three-step path-
way involving mitochondrial-, ER- and nuclear-localized enzymes.
Results from animal and cell culture experiments indicate that the
rate of DAG and PA biosynthesis, and the activity of TAG and Kennedy
pathway enzymes, inﬂuence the synthesis and fatty acid composition
of TAG, PC and PE. The initial step in the synthesis of PA is catalyzed
by a family of glycerol 3-phosphate acyltransferases (GPAT) that lo-
calize to the ER and outer mitochondrial membrane. Cell culture
and in vivo knockout mouse models show that TAG biosynthesis is
regulated by the localization and activity of GPAT isoforms. The ex-
pression of GPAT1 in the outer mitochondrial membrane is strongly
induced by insulin signaling via SREBP1c [53,54] and has a primary
function in channeling acyl-CoA into TAG in lipogenic tissues [55].
While PL synthesis in Gpat1−/−mice was unchanged, there was a sig-
niﬁcant reduction in the palmitate content of hepatic and cardiac PC
and PE, consistent with the substrate speciﬁcity of the enzyme
[56,57]. The acyl-CoA-dependent acylation of lyso-PA to form PA is
catalyzed by acylglycerolphosphate acyltransferase (AGPAT) 1–5,
polytopic integral membrane proteins of the ER with distinct tissue
expression proﬁles. AGPATs reportedly inﬂuence lipogenesis in adi-
pocytes and liver (reviewed in [58]) but their roles in phospholipid
synthesis are unknown. These data suggest that the redundancy and
capacity in the PA biosynthetic is necessary for channeling fatty
acids into TAG but has minimal inﬂuence on bulk PL synthesis.PA is the precursor for synthesis of CDP-DAG, cardiolipin and
phosphatidylinositol, or is dephosphorylated to DAG for synthesis of
PC and PE by the CDP-choline/ethanolamine (Kennedy) pathways
and acylation to TAG. The dephosphorylation of PA, a pivotal step in
de novo biosynthesis of glycerolipids, is catalyzed by a magnesium-
dependent PA phosphatase (PAP). S. cerevisiae PAP is encoded by
pah1 [59] and shares homology with mammalian LIPIN that was orig-
inally identiﬁed in a spontaneous mutant mouse (ﬂd) that exhibited
fatty liver dystrophy and severe lipodystrophy [60]. Pah1p activity is
regulated by phosphorylation and reversible association with the
ER and nuclear envelope via an extended amphipathic helix [61].
Multisite phosphorylation of Pah1p by Pho85p–Pho80p reduces cata-
lytic activity and association with membranes, while the Nem1p–
Spo7p phosphatase complex dephosphorylates and activates the en-
zyme [62–64]. Studies using yeast deletion stains indicate that Pah1p
regulates inositol-dependent lipid synthesis via the PA-dependent
Opi1p/Ino2p/Ino4p transcriptional complex, as well as controlling the
balance between PA and DAG utilization by the CDP-DAG and Kennedy
pathways. Deletion of pah1 results in reduced PC and TAGmass, but the
ER and nuclear envelope membranes proliferate, partially due to dere-
pression of lipid synthesis via the CDP-DAG pathway [61,63,65].
In mammalian cells, LIPIN-1, -2 and -3 regulate TAG and fatty acid
homeostasis in white and brown adipocytes, liver and skeletal muscle
but have a minor effect on the partitioning of PA or DAG into phos-
pholipid biosynthetic pathways. mTOR dependent phosphorylation
of LIPIN-1 was shown to prevent nuclear import where it represses
SREBP1c transcriptional activity and expression of lipogenic genes
[66]. Nuclear distribution of hepatic LIPIN-1 is also necessary for acti-
vation of fatty acid oxidation pathways via interaction with PPARα
and the PPARγ co-activator PGC-1α [67]. These transcriptional cir-
cuits are primarily involved in fatty acid homeostasis and do not di-
rectly inﬂuence the expression of phospholipid biosynthetic genes.
Consistent with the lack of effect of LIPIN activity on phospholipid
biosynthesis, Lipin-2 knockout mice have increased cerebellar accu-
mulation of PA but other phospholipids are unaffected [68]. In
McA-RH7777 hepatoma cells, ectopic expression or silencing of
LIPIN-1 enhances or suppresses, respectively, TAG, PC and PE synthe-
sis and secretion [69]. In contrast, the synthesis and secretion of TAG
from 14-day LIPIN-1 deﬁcient ﬂd mouse hepatocytes is increased, an
effect that is suppressed by adenovirus expression of LIPIN-1 [70].
Collectively, these studies have deﬁned essential roles for GPAT-1
and LIPIN in TAG synthesis, but scant evidence, except in yeast, that
this is coupled to changes in phospholipid synthesis. Rather, the avail-
ability of de novo synthesized PA or DAG is correlated with TAG syn-
thesis, either through substrate availability or the mTORC2 nutrient-
signaling pathway [71]. However, it should be noted that blocking
the ﬂux of DAG into phospholipid or TAG by manipulating the activity
of downstream enzymes causes a signiﬁcant diversion of substrate
and biosynthetic activity. For instance, diacylglycerol acyltransferase
(DGAT)1 overexpression [72] or knockout of both Dgat genes in
MEFs [73] results in decreased or increased Kennedy pathway activi-
ty, respectively. Blocking the PE and PC Kennedy pathways by liver-
speciﬁc knockout of CTP:phosphoethanolamine cytidylyltransferase
[74,75] or CCTα [76], respectively, signiﬁcantly increased TAG synthe-
sis as the result of substrate diversion and/or reduced TAG secretion.
Cell culture experiments have also demonstrated diversion of DAG
into TAG when the CDP-choline pathway is compromised [77],
suggesting a common pool of DAG is available to DGAT and CEPT/CPT.
2.3. Role of PC in very low density lipoprotein secretion
Excess fatty acid and cholesterol is esteriﬁed to form TAG and cho-
lesterol ester, respectively, seeding the formation of cytosolic lipid
storage droplets or, in the case of hepatocytes, very low-density lipo-
proteins (VLDL). This allows energy storage and export, and also
maintains membrane integrity by reducing cholesterol and fatty
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the concomitant synthesis of PC, which along with PE forms a sur-
rounding phospholipid monolayer. Mouse knockout models of hepat-
ic ER phospholipid metabolism have illuminated roles for speciﬁc PC
biosynthetic pathways in lipoprotein secretion [79,80]. Approximate-
ly 70% of hepatic PC synthesis is via the CDP-choline pathway with
the remainder synthesized via PE methylation. In mice, disruption of
Pcyt1a is lethal at embryonic day 3.5 [81], whereas liver-speciﬁc dele-
tion has no affect on viability despite a 25% decrease in hepatic PC
mass [82]. CCTα-deﬁcient murine hepatocytes have defective assem-
bly and secretion of VLDL, and efﬂux of cholesterol and phospholipid
to high-density lipoprotein, leading to accumulation of large LDs [83].
Pemt−/− mice display severe liver pathology when fed a choline-
deﬁcient diet, suggesting that PE methylation is essential when die-
tary choline availability is low, such as during starvation [84]. Despite
an adaptive increase in hepatic CCT activity and no overall change in
hepatic PC mass, male Pemt−/− mice fed a high-fat/high-cholesterol
diet are deﬁcient in the packaging and secretion of VLDL. Thus
PEMT-derived PC plays an important role in VLDL assembly in hepato-
cytes that cannot be compensated by the CDP-choline pathway. The
mechanism for this could involve the localization of PEMT to
mitochondrial-associated membranes (MAM), an ER-domain that is
in contact with mitochondria (see Section 4.1, Fig. 1). ER–mitochondri-
al contact zones could facilitate the concerted synthesis and channeling
of phosphatidylserine (PS)-derived PC into lipoprotein assembly. Alter-
natively, the methylation of PE could maintain optimal PC/PE ratios re-
quired for ER and Golgi secretion [85]. Increased content of the
non-bilayer lipid PE would increase negative membrane curvature
and affect the activity of curvature-sensitive proteins. For instance,
lipid packing and membrane curvature regulate ARF-GAP activity and
COPI-mediated transport [86].
2.4. Role of PC in intracellular triglyceride storage
Despite substrate partitioning between the glycerolipid pathways
described in Section 2.2, TAG deposition in LDs is coordinated
with the synthesis of PC at the level of CCT and PEMT regulation. A
role for CCT activity in regulation of LD size has been identiﬁed in
D. melanogaster S2 cells [87]. Although the CCTα ortholog CCT1 is
nuclear-localized in insect cells at steady-state, ﬂuorescence loss in
photobleaching experiments showed that CCT1 rapidly shuttles be-
tween the nucleus and cytoplasm under basal conditions, and local-
izes almost exclusively to the surface of LDs via its amphipathic
α-helix upon oleate-loading and LD expansion [87]. LD localization
of CCT1 was delayed following oleate treatment, suggesting a dynam-
ic process whereby nuclear/cytoplasmic shuttling allows CCT1 to
monitor the PC content on lipid droplets, translocating to the lipid
droplet surface to stimulate CDP-choline synthesis when PC content
is limiting. CCTα is also associated with LDs in oleate-treated mouse
macrophages [87] and proteomic studies have identiﬁed CCTα on iso-
lated lipid droplets from differentiated Caco-2/TC7 enterocytes [88].
Consistent with the reduced ratio of phospholipid/TAG as LD volume
increases, LD size is increased in hepatocytes and macrophages from
tissue-speciﬁc CCTα knockout mice [83], and in S2 cells in which
other key phospholipid biosynthetic enzymes are knocked down
[87]. Increased LD size could result from fusion of small LDs promoted
by decreased levels of PC in the surrounding phospholipid monolayer,
which acts as a surfactant to prevent lipid droplet coalescence [87].
Increased TAG synthesis due to shunting of DAG away fromphospholip-
id synthesis could also contribute to increased LD size in CCT-deﬁcient
cells [89].
It is unknown how CCT activity and CDP-choline formation on the
LD surface leads to changes in the PC content of LDs since the terminal
reaction in the Kennedy pathway is catalyzed by the ER/Golgi en-
zymes CEPT and CPT. CEPT protein and activity are not associated
with isolated LDs from A431 cells [88,90], but CDP-choline producedby CCTα on LDs could stimulate PC synthesis in adjacent ER mem-
branes (Fig. 1). The incorporation of PC into LDs could involve
phospholipid transfer proteins, perhaps facilitated by the close appo-
sition of LDs with ER membranes [91–94]. Alternatively, PC may be
incorporated by lateral diffusion through membrane junctions or
“bridges” joining the ER and LDs, as proposed in a model of LD bio-
genesis [95] and visualized by EM [96,97].
Concurrent with a decrease in the cellular PC/PE ratio, PEMT ex-
pression is induced upon differentiation of mouse 3T3-L1 ﬁbroblasts
into adipocytes [8]. Similarly, PEMT expression is induced in the adi-
pocytes of mice fed a high-fat diet, and adipocyte hypertrophy is ob-
served in Pemt−/− mice. Even though PEMT is an integral membrane
protein, it co-localizes to the outer monolayer of LDs in differentiated
3T3-L1 cells [8]. While the mechanism of PEMT association with lipid
droplets is unclear, it was recently demonstrated that GPAT4, an
integral membrane protein, that catalyzes the ﬁrst step in de novo
TAG synthesis, localizes to LDs in response to oleate treatment in S2
cells [97]. Topology determinations showed that GPAT4 has two
transmembrane domains that are unusually long for ER-spanning
α-helices suggesting that it may adopt a more favorable hydrophobic
hairpin structure within the phospholipid monolayer and underlying
hydrophobic core of the LD. Strikingly, GPAT4 was only localized to a
subset of LDs containing CCT1 that expanded in size upon oleate
treatment and not to a static population of LDs [97]. Enzymes in-
volved in the Lands cycle, such as lyso-PC acyltransferase-1 and −2,
and calcium-independent and -dependent PLA2, also affect LD size
and metabolism of core lipids, further supporting the essential role
of PC in regulating TAG storage [90,98,99].
2.5. Regulation of ER cholesterol homeostasis by PC
Because of their opposing effects on membrane ﬂuidity [100], PC
and cholesterol are maintained within narrow limits by metabolic
co-regulation [101]. The central mediators of membrane homeostasis
are the sterol regulatory-element binding proteins (SREBPs), which
regulate expression of a gene network involved in cholesterol and
fatty acid synthesis, and lipoprotein uptake. Three SREBP isoforms
in mammalian cells have separable but overlapping gene targets;
SREBP-1a activates both cholesterol and fatty acid synthesis, while
SREBP-1c and SREBP-2 are relatively speciﬁc for fatty acid and choles-
terol synthesis, respectively [102]. SREBPs are synthesized as inactive,
membrane-bound precursors localized in the ER. Vesicle-mediated
transport to the Golgi apparatus in response reduced cholesterol
levels results in the cleavage of SREBP by Golgi-resident proteases,
releasing a mature transcription factor that transports to the nucleus
to activate target genes [103]. The cholesterol ‘sensor’ is the trans-
membrane SREBP cleavage-activating protein (SCAP) that escorts
SREBPs from the ER to the Golgi apparatus, and INSIGS, which bind
oxysterols. Cholesterol binds directly to SCAP, resulting in a confor-
mation that favors binding to the ER-resident protein INSIG, which
in turn inhibits recruitment of the SCAP/SREBP complex into COPII
vesicles at ER exit sites [104]. In CHO cells, SREBP-2 processing is
inhibited when ER cholesterol levels reach a threshold of 5 mol% of
total ER lipids [105]. This threshold was lowered to 3 mol% in cells
overexpressing INSIG-1. Thus processing of SREBPs is ultimately
regulated by the cholesterol/phospholipid ratio of the ER, which is
relatively low compared to other organelles and sensitive to small
ﬂuctuations in cholesterol mass [105].
While this model elegantly explains negative feedback control of
cholesterol biosynthesis in response to cellular demands for membrane
cholesterol, it remains to be established how the SREBP pathway inte-
grates phospholipid and TAG metabolism to maintain overall mem-
brane homeostasis, and how this balance is perturbed in pathological
states. Importantly, in vivo studies show that SREBP-2 and SREBP-1c
are not coordinately regulated in hamster liver; sterol depletion leads
to an increase in the mature nuclear form of SREBP-2 but a decline in
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down-regulated in mice during fasting; however, SREBP-1c levels in-
crease 4- to 5-fold above non-fasted levels upon high-fat/high carbohy-
drate feeding, whereas SREBP-2 levels only return to non-fasted levels
[107]. Thus SREBP-1c is highly regulated by nutritional status compared
to SREBP-2.
Since phospholipid synthesis requires a supply of fatty acids, the dif-
ferential processing of SREBP isoforms inmammalian cells could be crit-
ical for the maintenance of phospholipid synthesis when cellular
cholesterol levels are elevated or in other situations where phospholip-
id demand is increased. SREBP-1 does not transcriptionally activate PC
biosynthetic genes but stimulates PC synthesis by increasing production
of pathway substrates and/or activators of CCTα [39,108]. Several stud-
ies have also shown that phospholipidmetabolism can regulate the pro-
cessing SREBP-1 orthologs in Drosophila melanogaster [109,110] and
Caenorhabditis elegans [111] by a negative feedback mechanism. The
latter study also showed that this mechanism is conserved in mamma-
lian cells. In HepG2 cells, siRNA-mediated knockdown of CCTα or CEPT
resulted in nuclear accumulation of SREBP-1 and increased expression
of target genes [111]. Decreasing PC synthesis did not affect SREBP-2
processing, and the effect on SREBP-1 processing was independent of
cholesterol. Similarly, in liver-speciﬁc CCTα knockout mice, hepatic nu-
clear SREBP-1c levels were increased relative to wild-type controls,
whereas nuclear SREBP-2 levels did not change. CCTα silencing in
HepG2 cells resulted in re-localization of Site-1 and Site-2 proteases
from the Golgi apparatus to the ER. These ﬁndings led to speculation
that lowering the PC/PE ratio in ERmembranes activates ARF-GAPby al-
tering membrane curvature, resulting in inhibition of anterograde
transport and constitutive processing of SREBP-1 in the ER. In support
of this theory, the ARF-GEF inhibitor brefeldin A causes transport-
independent processing of SREBP-2 by relocalizing Site-1 proteases
from the Golgi to the ER [112]. While ER retention of Site-1 and Site-2
proteases explains the role of PC metabolism in SREBP-1c processing,
it is unclear why SREBP-2 processing was not similarly effected by
changes in PC synthesis.
3. Role of PC metabolism in ER-stress pathways
3.1. Effect of PC depletion on ER-stress.
Inhibition of PC synthesis leads to the induction of a regulatory
program triggered by ER-stress termed the unfolded protein response
(UPR), which is comprised of three signaling pathways involving the
ER transmembrane sensors IRE1 (inositol requiring enzyme 1), PERK
(double strand RNA-activated protein kinase-like eukaryotic initia-
tion factor 2a kinase) and ATF6 (activating transcription factor-6).
When the ER is stressed by accumulation of misfolded proteins or
perturbations in lipid homeostasis, the UPR functions to reduce pro-
tein synthesis, increase protein degradation, expand ER membranes
and enhance protein folding. If these responses fail to reestablish
ER homeostasis, the UPR can trigger apoptotic cell death through
PERK-mediated activation of the pro-apoptotic factor C/EBP homolo-
gous protein (CHOP). An unambiguous role for PC synthesis in apoptotic
cell death associated with the UPR occurs in MT58 cells, Chinese
hamster ovary cells that express a temperature-sensitive CCTα allele
[113–115]. Incubation ofMT58 cells at the non-permissive temperature
of 40 °C results in depletion of PC by24 h and activation of CHOP at 48 h
[114]. MT58 cells are rescued by supplementation of the medium with
PC or lyso-PC, which can be utilized by the Lands pathway [115], indi-
cating that alternate sources of PC can bypass a requirement for the
CDP-choline pathway. Depletion of PC in MT58 cells results in dilation
and reorganization of rough ER, and accumulation of large lipid droplets
[116]. Surprisingly, PC depletion does not affect protein transport from
the ER, but inhibits protein transport in the Golgi apparatus, indicating
increased sensitivity of the Golgi apparatus to inhibition of PC synthesis
[116].3.2. Role of PC in cholesterol-induced ER-stress.
When storage of cholesterol ester in LDs is compromised, ER choles-
terol levels increase and negatively affect protein function leading to
ER-stress. Under these conditions, PC synthesis is increased to buffer
the cell against elevated membrane cholesterol and prevent toxicity
[39,117]. The induction of PC synthesis plays an important protective
role within the arterial wall, where internalization of oxidatively-
modiﬁed low-density lipoproteins bymacrophages and smoothmuscle
cells leads cholesterol accumulation and plaque formation. Under these
conditions, CCTα activity and PC synthesis are increased resulting in the
production of membrane whorls that act as ‘sinks’ to absorb the excess
cholesterol [117,118]. Treatment of cholesterol-loaded macrophages
with a protein phosphatase inhibitor blunts the increase in PC synthesis,
implicating a mechanism involving increased membrane binding and
activity of dephosphorylated CCTα [118]. Since cholesterol is a poor ac-
tivator of CCTα in vitro, other metabolites that induce CCT activity, such
as fatty acids and oxysterols [119], may activate PC synthesis in cells
taking up oxidized lipoproteins. If PC synthesis fails to keep pace with
cholesterol accumulation in the ER, the sarco/endoplasmic reticulum
calcium-ATPase (SERCA) is inhibited, leading to depletion of luminal
ER calcium stores and induction of the CHOP pro-apoptotic arm of
the UPR [120]. Importantly, the CCTα-mediated stress response to
cholesterol-loading protects macrophages from necrotic cell death
[121]. The difference in death responses to cholesterol toxicity (late-
stage apoptosis versus early-stage necrosis) in macrophage foam cells
may play a critical role in atherosclerotic plaque stability by protecting
against premature plaque rupture and thrombosis [122,123].
3.3. Regulation of the CDP-choline pathway during ER proliferation
IRE1-mediated intron splicing of X-box binding proten-1 (XBP-1)
mRNA leads to expression of a functional transcription factor and in-
duction of ER chaperones. Ectopic expression of spliced XBP-1 pro-
motes ER proliferation, increased expression and activity of CCTα
and CPT/CEPT activity, and increased PC and PE mass [124,125]. A
well-characterized example of ER-stress occurs in immature B-cells
upon differentiation into antibody-secreting plasma cells. The in-
creased protein load in the early secretory pathway of these cells
leads to proliferation of ER membranes that is in part fueled by
membrane translocation and activation of CCTα and PC synthesis
controlled by XBP-1 [125–127]. PC synthesis is also increased inde-
pendently of XBP-1 by the ATF6 signaling arm of the UPR in response
to increased ER-membrane protein levels [128]. As with other mech-
anisms of ER expansion in response to increased protein load, there is
an ‘overshoot’ in PC production [128,129] that is balanced by in-
creased PC degradation by calcium-independent PLA2 [130]. Similar
to SREBPs, ATF6 activation is regulated by ER-to-Golgi trafﬁcking
and proteolysis by Site-1 and Site-2 proteases [131]. Therefore, it is
conceivable that ATF6 signaling could be mechanistically linked to in-
creased SREBP-1c processing in a coordinated response to increased
cellular demand for fatty acids and phospholipids during membrane
expansion.
3.4. PC in palmitate-induced ER-stress
In addition to regulating cholesterol and fatty acid synthesis,
SREBPs also regulate the unsaturation of fatty acids by transcription
of stearoyl-CoA desaturase-1 (SCD1). SCD1 is expressed in the ER
where it catalyzes the Δ9-desaturation of palmitate (16:0) and stea-
rate (18:0) to palmitoleate (16:1n−9) and oleate (18:1n−9), re-
spectively. Unsaturated fatty acids activate the synthesis of TAG by
DGAT for incorporation and storage in LDs. In contrast, excess satu-
rates are poorly incorporated into TAG and accumulate in other lipids
or are oxidized [78,132]. Scd1−/− mice are resistant to high-fat/high
carbohydrate diet-induced weight gain and liver steatosis as a result
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In the livers of Scd1−/− mice, CCT and CPT activities are elevated and
PC content is increased 40% [135]. Conversely, expression of PEMT is
decreased by 80%, indicating a shift towards PC synthesis via the
CDP-choline pathway [135]. Increased CDP-choline pathway activity
could sequester excess saturated fatty acids in PC and prevent accu-
mulation in other potentially toxic lipids such as DAG and ceramide.
However, this protective mechanism may fail when saturated fatty
acids reach a critical level. Palmitate administered to CHO cells or
cardiomyoblasts is rapidly incorporated into ER phospholipids lead-
ing to impaired ER structure and integrity [136]. In HeLa cells, SCD1
knockdown decreased unsaturated fatty acids in phospholipid, and
induced the UPR and eventually apoptotic cell death [137]. Lyso-PC
acyltransferase 3, which preferentially incorporates polyunsaturated
fatty acids into PC via the Lands pathway, is up-regulated in SCD1
knockdown cells. Knockdown of lyso-PC acyltransferase-3 and SCD1
synergistically enhanced palmitate-induced UPR [137], suggesting
that a decrease in membrane phospholipid unsaturation causes ER
stress.
It is well established in rodentmodels that obesity induces ER-stress
and UPR in multiple tissues [138–140]. In obese mice, compromised
UPR signaling increases insulin resistance [138], whereas measures to
reduce ER stress improve insulin signaling and glucose tolerance
[141,142]. ER-stress markers are also increased in adipose tissue of
obese humans [143], and treatment with the chemical chaperone sodi-
umphenylbutyrate, a drug that reduces ER stress, partially alleviates in-
sulin resistance and pancreatic β-cell dysfunction in obese non-diabetic
subjects [144]. A recent proteomic and lipidomic analysis of the ER iso-
lated from the livers of obese leptin-deﬁcient (Lep−/−)mice revealed an
increase in the PC/PE ratio and mono-unsaturated fatty acid content of
phospholipids compared to non-obese controls [145]. These ﬁndings
were correlated with decreased SERCA activity in microsomes from
obese mouse livers. Importantly, silencing of PEMT activity normalized
the PC/PE ratio in obese mice, increased SERCA activity and decreased
markers of ER stress. Suppression of PEMT also improved glucose toler-
ance in Lep−/−mice, an observation that is consistent with earlier stud-
ies showing that Pemt−/−mice are protected from diet-induced obesity
and insulin resistance [146]. It is apparent from these results that in-
creased food intake stimulates synthesis of PC, consistentwith its essen-
tial role in the packaging of excess lipid in LDs and lipoproteins.
Eventually a distorted PC/PE ratio in ER membranes negatively impacts
calcium homeostasis and ER stress ensues. A future challenge will be to
translate these ﬁndings into mechanisms for targeting phospholipid
metabolism in chronic diseases of ER dysfunction, such as obesity and
diabetes.
4. Coordination of phospholipid synthesis at ER-organelle
contact zones
4.1. ER–mitochondrial contacts
The extended ER network forms stable or quasi-stable interactions
with other organelles when the spacing between opposingmembranes
is b30 nm, the predicted distance spanned by a tethering protein com-
plex(es) [147,148]. Sites ofmembrane contact identiﬁed bymicroscopic
and biochemical techniques include the Golgi apparatus [149], mito-
chondria [150,151], plasma membrane [152] and endosomes [153]. A
distinct ER domain termed the MAM forms dynamic contacts with mi-
tochondria that are hot-spots for lipid metabolism [154] and calcium
signaling that controls ER and mitochondrial stress and energetics
[155,156] (Fig. 1). MAM has features of smooth ER but is reportedly
enriched in lipid biosynthetic enzymes, including PEMT and PS
synthases [150,157,158], GPAT1 [159] and acyl-CoA synthase 4 [160].
PS synthesized in the MAM by PS synthases I or II is transferred to the
inner mammalian mitochondrial membrane by an unknown mecha-
nism where it is converted by PS decarboxylase to PE, which issubsequently exported to the ER and other organelles (Fig. 1). Reconsti-
tution of this pathway in permeabilized cells orwith isolated ER andmi-
tochondrial fractions is ATP-dependent but does not require soluble
protein factors [161,162]. PS synthases I and II are integral membrane
proteins that exchange serine for the head group of preexisting PC or
PE, respectively [163,164]. Although the bulk ER has PS biosynthetic ac-
tivity, the speciﬁc activity in MAM is signiﬁcantly greater [158]. How-
ever, enzyme activity proﬁles did not correlate with expression of
endogenous PS synthase I and overexpressed PS synthase II protein,
which are almost completely localized to MAM fractions isolated on
Percol gradients [158]. This could indicate the presence of another
ER-speciﬁc PS synthase isoform, or an inﬂuence of the ER membrane
environment on PS synthase activity.
PEMT activity is found in crude microsomes as well as MAM, how-
ever a 20 kDa isoform of the enzyme referred to as PEMT2 that
reacted with a carboxyl-terminal-speciﬁc antibody was absent from
the ER but detected exclusively in MAM [157]. The MAM-speciﬁc
PEMT is not an alternate promoter transcript since these have identi-
cal coding sequences [165,166], suggesting a post-transcription mod-
iﬁcation is involved in targeting it to the membrane contact site. In
vitro incubation of MAM and mitochondria with radiolabelled serine
and S-adenosylmethionine resulted in isotope incorporation into PC
[150,167]. This suggests a concerted lipid synthesis/transport path-
way wherein PS is made in the MAM, transported to PS decarboxylase
on the inner mitochondrial membrane for conversion to PE and sub-
sequently transferred to the MAM for methylation by PEMT2 (Fig. 1).
MAM could also contribute to hepatic lipoprotein secretion by con-
centrating acyl-CoA acyltransferase, DGAT2 and PS metabolic activi-
ties at a pre-Golgi site of nascent lipoprotein assembly [168,169].
Mitochondrial lipid biosynthetic and energetic capacity could then
be coordinated with lipoprotein assembly in the ER.
It is unlikely that the lipid biosynthetic enzymes localized to ER/mi-
tochondrial contact sites are sufﬁcient for stable tethering of opposing
membranes. However, putative tethering factors, including mitofusins
1 and 2 [151] and a voltage-dependent ion channel (VDAC)/IP3R/
GRP75 complex [148,170], have not been implicated in providing stable
contacts for lipid transport. In yeast, ER/mitochondrial contacts are de-
pendent on an ER–mitochondrial encounter structure (ERMES) com-
posed of four proteins; Mdm10, Mdm34, Mmm1 and Mdm12 that do
not have apparent mammalian homologues [171]. The ERMES complex
has a primary role in maintaining structural morphology of the mito-
chondria but does not directly participate in PS transport or conversion
to PE [148]. However, ERMES may interact with other ER shaping
reticulons to enhance PS decarboxylation in the mitochondria [172].
Perturbations in lipid metabolism at the MAM are linked to
Alzheimer disease [173,174]. Presenilin 1 and presenilin 2, components
of the γ-secretase complex that processes β-secretase-cleaved APP into
the Aβ40 and Aβ42 amyloidogenic fragments, are enriched in theMAM
based on co-fractionation with speciﬁc markers [173,175]. In these and
other studies [176,177], MAM isolated from different tissues contained
detergent-resistantmembranes (DRM), and are enriched in cholesterol,
ceramide and sphingolipid relative to bulk ER [173,176]. These ﬁndings
are consistent with the preferential association of presenilins with
DRMs [178]. Fibroblasts from Alzheimer patients and presenilin-null ﬁ-
broblasts have increased [3H]serine incorporation into PS and PE, in-
creased cholesterol esteriﬁcation, and more contact zones between
the ER andmitochondria [173]. This suggests that presenilin 1/2 expres-
sion is negatively correlated with increased MAM-associated lipid me-
tabolism, indicating these proteins are negative regulators of MAM
function, and that Alzheimer disease could be a consequence of altered
MAM activity that affects other downstream amyloidogenic pathways.
4.2. Lipid metabolism at other ER-organelle contact zones
ER contacts with other organelles have been identiﬁed at the mi-
croscopic level but, unlike the mitochondria and PM, the isolation of
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been achieved. Electron tomography has revealed contacts between the
ER and trans-Golgi cisternae that could mediate lipid and cholesterol
transport between these compartments [149,179]. Oxysterol binding
protein coordinates the formation of a sterol-dependent lipid transport
complex that contains ceramide transfer protein [180], the PI/PC-transfer
protein Nir2 and VAMP-associated protein, a type II ER protein [181]
(Fig. 1). The recruitment of these lipid transfer proteins regulates the
levels of DAG, sphingomyelin and phosphatidylinositol 4-phosphate in
the Golgi apparatus and secretory events that dependent on these lipids.
ER-Golgi contacts formed by these proteins have not been identiﬁed by
microscopic techniques nor are they amenable to isolation, suggesting
the involvement of weak protein-lipid interactions.
Although peroxisomes likely derive their membrane lipids during
biogenesis from the ER [182,183], there is also rapid delivery of PS to
peroxisomes in vitro that is stimulated by ATP and soluble transport
proteins [184] (Fig. 1). The transfer of PS to peroxisomes in yeast is sim-
ilar to ER–mitochondrial transport but it is unknown if stable mem-
brane contacts are involved or whether other lipids are transported to
peroxisomes in a similar manner.
Yeast andmammalian cells have clearly identiﬁed contacts between
the tubular ER and PM that are important communication junctions
with the external environment. Inmammalian cells, the luminal ER cal-
cium sensor stromal interaction molecule-1 (STIM-1) interacts with
Orai, the pore forming subunit of the store-operated calcium channel,
leading to increased calcium entry in response to ER calcium depletion
[185]. STIM-1-regulated calcium entry regulates a variety of down-
stream signaling pathways involved in cell proliferation, differentiation
and apoptosis (reviewed in [186]). Yeast contain extensive contacts be-
tween the PM and underlying cortical ER that involve the ER-resident
proteins Tcb1p1/2/3, Ist1p, Scs2p and Scs21p [187]. PM-cortical ER con-
tacts are also sites for PI 4-phosphatemetabolism and sterol trafﬁcking/
signalingmediated by Sac1p and oxysterol binding proteins, respective-
ly [188,189] (Fig. 1). The importance of these contacts to ER function is
illustrated in deletion stains, which have collapsed cortical ER and accu-
mulation of cytoplasmicmembrane tubules and sheets, accumulation of
PI 4-phosphate and induction of the UPR [187].
5. Regulation of ER architecture by phospholipid metabolism
5.1. Membrane deformation by lipid metabolic enzymes
The ER is organized into several functional domains; a nuclear en-
velope perforated with nuclear pore complexes, perinuclear planar
arrays of membrane sheets studded with ribosomes, COPII export
pathways that emanate from transitional ER and a branched, tubular
network that extends to the cell periphery. The complex membrane
landscape of organelles such as the ER is dictated by 1) the relative
content of phospholipids with intrinsic curvature properties and
2) association of modifying proteins that that change the curvature
of membranes by direct interaction [190,191]. While there are exam-
ples of membrane curvature induction involving both lipids and mod-
ifying proteins [191], the localized asymmetric distribution of lipids
has not been implicated in generation of ER membrane heterogeneity
[192]. Rather, the complex spatial organization of the ER depends on
membrane-deforming proteins and interaction with the cytoskeletal
network [193]. Positive membrane curvature evident in tubular ER
and at the ends of planar sheets is the result of ER-shaping reticulons
and DP1/YOP1 proteins that are sufﬁcient to maintain tubular ER in
cells and which generate lipid tubes in vitro by oligomerization and
asymmetric bilayer insertion.
As summarized in a recent review [3], many ER-localized enzymes
are polytopic, integral membrane proteins that could theoretically
form a hydrophobic ‘wedge’ and induce membrane curvature in a
manner similar to reticulons. Coupled with this, enzyme activity
could augment or counter membrane curvature depending on thephysical properties of the lipid substrate(s) and product(s). Other
lipid biosynthetic enzymes are amphitropic in nature and reversibly
interact with membranes by amphipathic helices or other mecha-
nisms, potentially effecting membrane curvature in response to the
lipid environment. Alternatively, helices could bind to membranes
in response to intrinsic curvature, so called curvature-sensing do-
mains [86,194]. While there are no examples of integral membrane
enzymes that affect ER architecture, several amphitropic lipid
metabolic enzymes have been implicated in curvature induction of
biological membranes in vitro and in cultured cells. The rate-limiting
enzyme in the CDP-choline branch of the Kennedy pathway, CCTα
see Section 2.1), is involved in formation of membrane invaginations
of the inner and outer nuclear envelope that comprise a tubular
(100–500 nm diameter), branching nucleoplasmic reticulum (NR)
[195,196] (Fig. 1). NR invaginations, which are ubiquitously observed
in cultured cells and tissues [197], are extensions of the ER and
cytoplasm that bring nuclear pore complexes deep within the nucle-
oplasm and thus may facilitate nucleo-cytoplasmic transport and
communication [198]. Formation of the NR in cultured cells is stimu-
lated by CCTα expression and activation by oleate, and requires
domain M. Amino acid substitutions in domain M that enhance mem-
brane binding cause the formation of stacks of intranuclear lipid
tubules (25 nm diameter) that contain CCTα [196]. NR formation by
CCTα also requires lamins [196,199], suggesting that he nuclear lamina
provides a framework that supports invagination of the NE. Incubation
of recombinant CCTα with liposomes of heterogeneous composition
also caused the formation of 50 nm tubules [195]. Tubulation of lipo-
somes composed of PC/PG was highly efﬁcient compared to heteroge-
neous lipid mixtures, resulting in uniform non-branching tubules of
12 nm diameter estimated to have 50 molecules of phospholipid per
mole of CCTα [199]. Under the same conditions, domain M peptides
were sufﬁcient to tubulate liposomes. Based on the distribution and
the extent of tubule formation at differing CCTα concentrations, it was
proposed that CCTα could also sense and preferentially bind mem-
branes with positive curvature [199]. This suggests that CCTα alters
the structure of the nuclear envelope, inducing invaginations that
are dependent on lipid composition and nuclear lamins. Membrane-
modifying functions are likely not restricted to the inner NE since
CCTα is exported to the cytoplasm in response to cell proliferation
and enzyme activation where it could remodel the tubular and planar
ER network depending on localized lipid composition and intrinsic cur-
vature. Thus CCTα translocation to membranes in response to changes
in lipid composition adjusts ﬂux through the CDP-choline pathway
and integrates this with localized membrane remodeling.
Calcium-dependent cPLA2α catalyzes the release of arachidonate
from the sn-2 position of PC upon calcium binding by its C2 domain
and translocation to membranes. [200]. cPLA2α interacts with the
perinucler ER, NE and Golgi apparatus depending on the concentra-
tion and duration of calcium transients [201]. Translocation of
cPLA2α is essential for the enzyme to access its substrate but the C2
domain is also capable of inducingmembrane curvature. The formation
of intra-cisternal Golgi tubules is dependent on cPLA2α translocation
and enzyme activity [202,203]. On the other hand, Fc-receptor-
dependent phagocytosis required cPLA2α but enzyme activity was dis-
pensable and the isolated C2 domain was sufﬁcient to reconstitute
phagocytosis [203]. The calcium-dependent tubulation of giant PC lipo-
somes by the C2 domain was sensitive to mutation of key hydrophobic
residues that mediate membrane insertion [204]. This suggests a
model wherein the cPLA2α C2 domain penetrates one leaﬂet of the bi-
layer and, if the leaﬂets remain strongly coupled, an area discontinuity
results in positive membrane curvature. Production of lyso-lipids by
cPLA2α could enhance positive curvature by virtue of their intrinsic
wedge-shape [203].
The amphipathic helix of LIPIN/Pah1p is required for association
with the nuclear envelope [61] and alteration of nuclear shape [66].
Amphipathic helices with a weakly charged polar face enriched in
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curved membranes characterized by loosely packed lipid head groups
[205]. The amphipathic helix in Pah1p ﬁts the criteria for this type
of lipid-packing sensor. However, Pah1p appears to associate with
planar membranes (ER and NE) and not the tubular ER network in
yeast. Mammalian LIPIN-1 has a similar N-terminal amphipathic
helix that has not been implicated in membrane binding. However,
similar to Pah1p, LIPIN-1 also regulates nuclear membrane structure
by a mechanism that does not involve direct membrane interaction.
Dephosphorylation and nuclear import of LIPIN-1 increased the
elipticity of the nucleus, which coincides with suppression of SREBP
activity [66]. Recent independent identiﬁcation of LIPIN-1 as a factor
in NE breakdown during mitosis implicates the production of DAG
as a catalyst in PKC phosphorylation of lamin B and disassembly of
the nuclear lamina [206]. In this scenario, DAG synthesis by LIPIN-1
at the inner NE controls the phosphorylation status of nuclear lamins,
contributing to subtle shape changes that could affect gene expres-
sion or complete lamin disassembly during mitosis. While many pro-
teins have been identiﬁed that contain membrane curvature inducing
domains, CCTα, PLA2α and LIPIN-1 are unique in their capacity to also
enzymatically modify membrane phospholipid composition.
5.2. Tubular ER dynamics and phospholipid synthesis
In mammalian cells, phosphatidylinositol, phosphatidylglycerol
and cardiolipin are synthesized from CDP-DAG made by CDP-DAG
synthase (CDS) 1 and 2 [207-209]. CDS1 has several putative trans-
membrane domains and the overexpressed epitope-tagged enzyme
is uniformly localized to the tubule ER and nuclear envelope [210].
Overexpression studies in cultured cells indicate that CDS is
not limiting for phosphatidylinositol synthesis [207]. Rather, the
rate-limiting enzyme is phosphatidylinositol synthase (PIS), which is
encoded by a single ubiquitously expressed gene [207]. GFP-tagged
PIS localizes to the tubular ER network with CDS but is also present in
an unusual, high-mobilitymembrane/vesicular compartment that ema-
nates from the ER by a Sar1-dependent mechanism and ﬂeetingly con-
tacts PM-ER junctions that mediate store operated calcium entry [211].
Based on density gradient fractionation, the mobile vesicle fraction has
greater PIS activity compared to the bulk ER and only accommodates
catalytically active enzyme. Interestingly, CDS1 and 2 are excluded
from this fraction indicating that CDP-DAG packaged into vesicles at
the ER is sufﬁcient to maintain the synthesis and delivery of PI to
other organelles. Recently, similar PIS-enriched domains were identi-
ﬁed at the leading edge of dynamic ER tubules that track on microtu-
bules and undergo homotypic fusion [212]. The extension and fusion
of these tubules required Rab10; silencing or expression of a
GDP-locked form in COS cells resulted in loss of tubular ER and prolifer-
ation of a cisternal network. Interestingly, CEPT was also co-localized
with PIS and Rab10 indicating that these ER tubules could also require
PC synthesis for extension and/or fusion. These dynamic ER structures
could be a site for lipid synthesis that, depending on recruitment of
GTPases and other factors, extend and fuse or detach to form mobile
lipid biosynthetic platforms that deliver lipids to other organelles.
6. Conclusions
Based on recent studies demonstrating synthesis of phospholipids
in speciﬁc ER domains, a future challenge will be to understand
where phospholipid synthesis and catabolism occur in the ER and
how this is integrated with ER-speciﬁc functions. The developing
theme is that of zones of active lipid metabolism within a vast ER net-
work that are highly dynamic and coordinated with activities occur-
ring in the Golgi apparatus, mitochondria and plasma membrane.
Moreover, changes in phospholipid metabolism that occurs in these
zones could inﬂuence ER function compared to the bulk compart-
ment, including localized changes in phospholipid composition thataffect cholesterol synthesis, UPR and organelle contact sites. This ulti-
mately impacts cell physiology and is beginning to be understood at
the level of relevant human diseases.
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